Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:30 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Nantahala Capital Management LLC | 1,794,141 9.990% | 1,794,141 (New Position) | Filing History |
| 2024-11-13 5:14 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | AMR Action Fund L.P. | 876,888 4.900% | 876,888 (New Position) | Filing History |
| 2024-11-04 4:05 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Burbank John Howard III | 510,205 2.900% | 510,205 (New Position) | Filing History |
| 2024-10-28 4:01 pm Purchase | 2024-09-30 | 13G | BIOMX INC UNIT 1 COM & 1 WT EX PHGEU | Centaurus Investments Ltd | 560,267 3.100% | 560,267 (New Position) | Filing History |
| 2024-07-17 8:40 pm Purchase | 2024-07-15 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 1,787,765 9.990% | 529,983 (+42.14%) | Filing History |
| 2024-07-11 6:47 pm Purchase | 2024-07-09 | 13D | BiomX Inc. PHGE | James E. Flynn | 15,558,445 9.990% | 14,947,435 (+2446.35%) | Filing History |
| 2024-05-30 7:26 pm Unchanged | 2024-05-30 | 13D | BiomX Inc. PHGE | James E. Flynn | 611,010 8.750% | 0 (Unchanged) | Filing History |
| 2024-03-26 4:30 pm Purchase | 2024-03-26 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 933,058 15.600% | 477,827 (+104.96%) | Filing History |
| 2024-03-25 3:35 pm Purchase | 2024-03-15 | 13G | BiomX Inc. PHGE | AMR Action Fund L.P. | 305,487 5.500% | 305,487 (New Position) | Filing History |
| 2024-03-22 5:44 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | James E. Flynn | 611,010 11.060% | 611,010 (New Position) | Filing History |
| 2024-03-19 9:11 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 1,257,782 19.900% | 797,601 (+173.32%) | Filing History |
| 2024-03-08 4:30 pm Purchase | 2024-03-06 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 460,181 9.900% | 4,832 (+1.06%) | Filing History |
| 2024-02-13 1:09 pm Sale | 2023-12-31 | 13G | BiomX Inc. PHGE | MMCAP International Inc. SPC | 152,799 3.220% | -69,489 (-31.26%) | Filing History |
| 2024-02-02 5:07 pm Sale | 2023-12-31 | 13G | BiomX Inc. PHGE | JOHNSON & JOHNSON JNJ | 211,340 4.600% | -2,000 (-0.94%) | Filing History |
| 2024-01-30 4:05 pm Purchase | 2024-01-30 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 455,232 9.900% | 180,133 (+65.48%) | Filing History |
| 2023-09-29 09:20 am Purchase | 2023-05-04 | 13G | BiomX Inc. PHGE | Centaurus Investments Ltd | 283,971 6.200% | 283,971 (New Position) | Filing History |
| 2023-06-23 4:50 pm Purchase | 2023-05-04 | 13G | BiomX Inc. PHGE | Burbank John Howard III | 459,819 9.990% | 459,819 (New Position) | Filing History |
| 2023-05-08 4:43 pm Purchase | 2023-05-04 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 455,349 9.900% | 101,700 (+28.76%) | Filing History |
| 2023-03-17 4:19 pm Purchase | 2023-02-27 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 353,649 10.500% | 124,600 (+54.40%) | Filing History |
| 2023-03-08 5:22 pm Purchase | 2023-02-27 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 275,099 8.100% | 275,099 (New Position) | Filing History |